MSCI Inc. (MSCI) CFO earns 5,639 performance stock options after goals met

Rhea-AI Filing Summary

MSCI Inc.'s Chief Financial Officer, Andrew C. Wiechmann, reported an equity award of performance stock options. On January 26, 2026, he was credited with 5,639 performance stock options to purchase MSCI common stock at an exercise price of $554.52 per share.

The options were originally granted on February 2, 2023 and relate to a performance period from January 1, 2023 through December 31, 2025. A board committee certified that the performance condition was achieved for 5,639 shares, and the options are scheduled to vest on February 2, 2026, subject to continued service.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Wiechmann Andrew C.

Role Chief Financial Officer

Type	Security	Shares	Price	Value
Grant/Award	Option to purchase common stock	5,639	$0.00	--

Holdings After Transaction: Option to purchase common stock — 5,639 shares (Direct)

Footnotes (1)

1. [object Object]

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Wiechmann Andrew C.

(Last) (First) (Middle)

MSCI INC.

7 WORLD TRADE CENTER, 250 GREENWICH ST.

(Street)

NEW YORK NY 10007

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
MSCI Inc. [ MSCI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

3. Date of Earliest Transaction (Month/Day/Year)
01/26/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Option to purchase common stock	$554.52	01/26/2026		A		5,639(1)		02/02/2026	02/02/2033	Common Stock	5,639	$0	5,639	D

Explanation of Responses:

1. Represents the number of performance stock options ("PSOs") to purchase common stock earned by the reporting person following the certification by the Compensation, Talent and Culture Committee on January 26, 2026 of the achievement of the performance condition applicable to the PSOs. The PSOs were granted on February 2, 2023 and vest on the third anniversary of the grant date, subject to continuous service through such date and satisfaction of the performance condition for the performance period from January 1, 2023 and ending on December 31, 2025. The performance condition for the PSOs was met with respect to 5,639 shares of common stock, and the PSOs are scheduled to vest on February 2, 2026.

Remarks:

	/s/ Cecilia Aza, attorney-in-fact	01/28/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did MSCI (MSCI) disclose in this Form 4 for its CFO?

The filing shows MSCI’s Chief Financial Officer, Andrew C. Wiechmann, was credited with 5,639 performance stock options. These options are tied to MSCI common stock and reflect compensation earned after a committee certified achievement of the applicable performance condition.

How many performance stock options did the MSCI CFO earn?

The CFO earned 5,639 performance stock options to purchase MSCI common stock. This number reflects the portion of the award that met the defined performance condition over the January 1, 2023 to December 31, 2025 performance period.

What is the exercise price of the MSCI CFO’s new stock options?

The options have an exercise price of $554.52 per share. This means the CFO can purchase MSCI common stock at $554.52 per share once the options vest and are exercisable, assuming all vesting conditions are satisfied.

When do the MSCI CFO’s performance stock options vest?

The performance stock options are scheduled to vest on February 2, 2026. Vesting depends on the CFO remaining in continuous service through that date, in addition to the previously satisfied performance condition.

What performance period applied to the MSCI CFO’s performance stock options?

The options are tied to a performance period running from January 1, 2023 through December 31, 2025. A board committee certified on January 26, 2026 that the performance condition was achieved for 5,639 shares.

Is the MSCI CFO’s Form 4 transaction a direct ownership award?

Yes. The Form 4 lists the 5,639 performance stock options as directly owned by the CFO. There is no indication in the disclosure that the award is held through an indirect entity or third-party structure.